Husam Abdel-Qadir

Husam Abdel-Qadir holds the prestigious Canada Research Chair (Tier 2) in Cardiovascular Disease Epidemiology and Outcomes at the University of Toronto, effective April 1, 2024, funded by the Canadian Institutes of Health Research.

His research centers on cardio-oncology, specifically investigating cardiovascular complications from cancer therapies including chemotherapy-induced cardiomyocyte damage and radiation-induced coronary artery disease, pericarditis, and valve damage—particularly in women with breast cancer. He also studies atrial fibrillation's role in elevating stroke and heart failure risks, developing predictive models for cardiovascular disease prevention in cancer survivors.

His scientific recognition includes:

• Canada Research Chair (Tier 2) in Cardiovascular Disease Epidemiology and Outcomes

Dr. Abdel-Qadir leads a research team generating evidence to guide clinical management of cardiovascular risks during cancer treatment. His work bridges cardiology and oncology to improve long-term outcomes for cancer patients, supported by the Canadian Institutes of Health Research through the Canada Research Chairs program.